MENU
FHTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Foghorn Therapeutics (FHTX) Earnings Date & Reports

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more

A.I. Advisor
published Earnings

FHTX is expected to report earnings to rise 2.84% to -25 cents per share on March 05

Foghorn Therapeutics FHTX Stock Earnings Reports
Q4'25
Est.
$-0.26
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.12
The last earnings report on November 05 showed earnings per share of -25 cents, beating the estimate of -33 cents. With 127.01K shares outstanding, the current market capitalization sits at 274.84M.
View a ticker or compare two or three
FHTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FHTX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
500 Technology Square
Phone
+1 617 586-3100
Employees
116
Web
https://www.foghorntx.com